VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
40 hedge funds and large institutions have $203M invested in Verona Pharma in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.21% less ownership
Funds ownership: 7.91% → 7.71% (-0.21%)
13% less capital invested
Capital invested by funds: $234M → $203M (-$31.3M)
88% less call options, than puts
Call options by funds: $4K | Put options by funds: $33K
Holders
40
Holding in Top 10
3
Calls
$4K
Puts
$33K
Top Buyers
| 1 | +$4.62M | |
| 2 | +$2.71M | |
| 3 | +$2.09M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$125K |
| 5 |
FA
Forefront Analytics
West Conshohocken,
Pennsylvania
|
+$96.4K |
Top Sellers
| 1 | -$1.64M | |
| 2 | -$1.37M | |
| 3 | -$118K | |
| 4 |
QSS
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
|
-$92K |
| 5 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
-$58K |